Natural Product: NPC603790

Natural Product IDNPC603790
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
KBHLNNQHHPFDSG-VTGIHGMASA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2059294
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey KBHLNNQHHPFDSG-VTGIHGMASA-N
Standard InCHI InChI=1S/C19H34O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17-18(20)16(2)22-19(17)21/h15-16,18,20H,3-14H2,1-2H3/b17-15+/t16-,18+/m1/s1
SMILES CCCCCCCCCCCCC/C=C1/C(=O)O[C@H](C)[C@@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   310.25 Volume:   349.721
?
Van der Waals volume.
Dense:   0.887 LogP:   5.94
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.198
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.182
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   12.0 Rigid Bonds:   7.0
TPSA:   46.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   1.0 Rings:   1.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.316 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.27 Fsp3:   0.842
MCE-18:   14.8
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.613 Fluc inhibitor:   0.103
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.044
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.018
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.933 Promiscuous compounds:   0.206

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.031 MDCK Permeability:   -4.731
Pgp-inhibitor:   0.026 Pgp-substrate:   0.024
PAMPA:   0.003
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.899
20% Bioavailability (F20%):   0.971 30% Bioavailability (F30%):   0.996
50% Bioavailability (F50%):   0.949

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.007 MRP1:   0.646
Plasma Protein Binding (PPB):   99.342% Volume Distribution (VD):   1.119
Fu: 0.896%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.845
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.402
BSEP inhibitor:   0.806

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.918
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.089
CYP2C9-inhibitor:   0.075 CYP2C9-substrate:   0.078
CYP2D6-inhibitor:   0.204 CYP2D6-substrate:   0.117
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.04
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.193 Half-life (T1/2):  0.807

ADMET: Toxicity

hERG Blockers:  0.223 hERG Blockers (10um):  0.717
Human Hepatotoxicity (H-HT):  0.728 Drug-induced Liver Injury (DILI):  0.549
AMES Toxicity:  0.595 Rat Oral Acute Toxicity:  0.554
Maximum Recommended Daily Dose:  0.762 Skin Sensitization:  1.0
Carcinogencity:  0.619 Eye Corrosion:  0.075
Eye Irritation:  0.902 Respiratory Toxicity:  0.864
Drug-induced Neurotoxicity:  0.2 Ototoxicity:  0.332
Hematotoxicity:  0.629 Drug-induced Nephrotoxicity:  0.875
Genotoxicity:  0.004 RPMI-8226 Immunitoxicity:  0.195
A549 Cytotoxicity:  0.982 Hek293 Cytotoxicity:  0.504
BCF:   1.016
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.662
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.104
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.38
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO61198 Mollinedia marliae Genus Monimiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT861 Individual protein Isocitrate dehydrogenase [NADP] cytoplasmic Homo sapiens Activity = 110.8 % PMID[26508549]
NPT861 Individual protein Isocitrate dehydrogenase [NADP] cytoplasmic Homo sapiens Activity = 113.7 % PMID[26508549]
NPT29646 Single protein 14-3-3 protein epsilon Homo sapiens Inhibition n.a. n.a. % PMID[25205188]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell line HT-29 Homo sapiens Inhibition n.a. n.a. % PMID[25205188]
NPT28438 Unchecked Unchecked n.a. Inhibition n.a. n.a. % PMID[22578462]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC603790 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC47148
0.8485 Intermediate Similarity NPC605151
0.8 Intermediate Similarity NPC150502
0.7568 Intermediate Similarity NPC604911
0.6053 Remote Similarity NPC125365
0.6053 Remote Similarity NPC256640
0.6053 Remote Similarity NPC51809
0.6053 Remote Similarity NPC301207
0.6053 Remote Similarity NPC221095
0.6053 Remote Similarity NPC279214
0.6053 Remote Similarity NPC16279
0.6053 Remote Similarity NPC474818
0.6053 Remote Similarity NPC49302
0.6053 Remote Similarity NPC176329
0.6053 Remote Similarity NPC205615
0.575 Remote Similarity NPC229799
0.575 Remote Similarity NPC284472
0.575 Remote Similarity NPC474959
0.575 Remote Similarity NPC310450
0.575 Remote Similarity NPC286770
0.575 Remote Similarity NPC11383
0.5641 Remote Similarity NPC608765
0.5641 Remote Similarity NPC609320
0.561 Remote Similarity NPC473471

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC603790 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data